Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gestational thrombocytopenia: a prospective study

M Ruggeri1, C Schiavotto, G Castaman

  • 1Department of Hematology, San Bortolo Hospital, Vicenza, Italy.

Haematologica
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply.

Journal of thrombosis and haemostasis : JTH·2018
Same author

The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH.

Journal of thrombosis and haemostasis : JTH·2018
Same author

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Thrombopoietin receptor agonists in hereditary thrombocytopenias.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Fifth Åland Island conference on von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same journal

Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myeloma.

Haematologica·2026
Same journal

Incidence and predictors of recurrent venous thromboembolism after isolated distal deep vein thrombosis: a <i>post-hoc</i> analysis of the RIDTS trial.

Haematologica·2026
Same journal

Philadelphia positive T-acute lymphoblastic leukemia: a Mayo Clinic series.

Haematologica·2026
Same journal

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Haematologica·2026
Same journal

Reframing leukemia-niche interactions: the emerging role of the marrow adipocyte lineage.

Haematologica·2026
Same journal

A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.

Haematologica·2026
See all related articles

Gestational thrombocytopenia (GT) typically resolves within months postpartum. However, this condition can recur in future pregnancies, though severe neonatal complications are rare, supporting conservative management.

Area of Science:

  • Obstetrics
  • Hematology
  • Perinatology

Background:

  • Gestational thrombocytopenia (GT) is a common pregnancy complication.
  • Limited data exist on the natural history and recurrence of GT in subsequent pregnancies.

Purpose of the Study:

  • To investigate the natural history of gestational thrombocytopenia.
  • To assess the recurrence rate of thrombocytopenia in subsequent pregnancies.
  • To evaluate neonatal outcomes in pregnancies complicated by GT.

Main Methods:

  • Prospective study of 37 patients with GT over 41 pregnancies (June 1987-December 1993).
  • Monitoring of maternal platelet counts, obstetric complications, and neonatal platelet counts.
  • Follow-up of maternal platelet normalization and recurrence in subsequent pregnancies.

Related Experiment Videos

Main Results:

  • Vaginal delivery occurred in 80% of pregnancies; no maternal bleeding episodes required transfusion.
  • No significant neonatal bleeding occurred; only one newborn had severe thrombocytopenia at birth, resolving within 10 days.
  • Maternal platelet counts normalized within 1-5 months postpartum in most cases, with mild thrombocytopenia persisting in some.
  • Thrombocytopenia recurred in all four patients who had a second pregnancy.

Conclusions:

  • Gestational thrombocytopenia rarely causes significant bleeding during pregnancy or delivery.
  • GT typically resolves spontaneously postpartum, but recurrence in subsequent pregnancies is common.
  • Conservative management is recommended due to the low risk of severe neonatal thrombocytopenia.